Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

42019-78-3Fenofibrate EP Impurity A

● Auf Lager

Katalog-Nr.::	VL59001
CAS-Nr.::	42019-78-3
Summenformel::	C₁₃H₉ClO₂
Molare Masse::	232.66

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 42019-78-3

Parent drug

Fenofibrate

IUPAC-Name

(4-chlorophenyl)(4-hydroxyphenyl)methanone

Pharmakopöe-Synonyme

Fenofibrate Related Compound A

Other Synonyms

4-Hydroxy-4′-chlorobenzophenone; 4-(4-chlorobenzoyl)phenol; 4-Chloro-4`-hydroxybenzophenone; 4-p-Chlorobenzoylphenol; 4-chlorophenyl 4-hydroxyphenyl ketone; 4-(4-chlorobenzoyl)-phenol

Smile

C1=CC(=CC=C1C(=O)C2=CC=C(C=C2)Cl)O

InChI

InChI=1S/C13H9ClO2/c14-11-5-1-9(2-6-11)13(16)10-3-7-12(15)8-4-10/h1-8,15H

Beschreibung

Fenofibrate EP Impurity A, also referred to in pharmacopoeias as Fenofibrate Related Compound A, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Fenofibrate. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications. Fenofibrate EP Impurity A (CAS No. 42019-78-3) or (4-chlorophenyl)(4-hydroxyphenyl)methanone is an impurity of Fenofibrate. Fenofibrate is used together with a proper diet to reduce and treat high cholesterol and triglyceride levels in the blood.